Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Disease management improves ESRD outcomes.

J J Sands1

  • 1Fresenius Medical Care North America, Celebration, FL 34747, USA. Jeffrey.Sands@fmc-na.com

The International Journal of Artificial Organs
|March 23, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vascular access 2007.

Minerva urologica e nefrologica = The Italian journal of urology and nephrology·2007
Same author

Dedicated outpatient vascular access center decreases hospitalization and missed outpatient dialysis treatments.

Kidney international·2006
Same author

Antibodies to prothrombin, factor V, and beta2-glycoprotein I and vascular access thrombosis.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2001
Same author

Increasing AV fistulas: revisiting a time-tested solution.

Seminars in dialysis·2000
Same author

Antibodies to topical bovine thrombin correlate with access thrombosis.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2000
Same author

Intervention based on monthly monitoring decreases hemodialysis access thrombosis.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·1999
Same journal

Therapeutic plasma exchange added to CRRT combined with hemoperfusion in wasp sting-associated AKI: A multicenter retrospective cohort study.

The International journal of artificial organs·2026
Same journal

Development of an early prediction model for ICU-acquired weakness in sepsis using PNI and SII.

The International journal of artificial organs·2026
Same journal

Foot care behaviors and perceived exercise benefits and barriers in diabetic hemodialysis patients.

The International journal of artificial organs·2026
Same journal

First clinical experience with citrate-anticoagulated CVVHD-based low-flow ECCO<sub>2</sub>R in severe hypercapnic respiratory failure.

The International journal of artificial organs·2026
Same journal

Carboxyhemoglobin levels for the detection of hemolysis in patients supported by left ventricular assist devices: A case series.

The International journal of artificial organs·2026
Same journal

Evaluation of arteriovenous fistulas of obtuse anastomosis in reducing thrombosis using computational fluid dynamics.

The International journal of artificial organs·2026
See all related articles

Disease management programs for end-stage renal disease (ESRD) significantly reduce mortality and hospitalizations while cutting costs. These programs improve patient satisfaction and quality of life, demonstrating their effectiveness in ESRD care.

Area of Science:

  • Nephrology
  • Healthcare Management
  • Public Health Policy

Background:

  • Renal disease management organizations report success in reducing mortality and hospitalizations.
  • Key components include risk assessment, predictive modeling, evidence-based guidelines, and nurse care managers.
  • Patient self-management education is crucial for program success.

Purpose of the Study:

  • To evaluate the impact of disease management programs on clinical outcomes and healthcare costs in end-stage renal disease (ESRD).
  • To define the full implications of disease management by measuring clinical outcomes and total healthcare costs.
  • To inform United States healthcare policy regarding ESRD management.

Main Methods:

  • Standardized use of risk assessment and predictive modeling.

Related Experiment Videos

  • Implementation of evidence-based guidelines and process/outcomes measurement.
  • Inclusion of patient self-management education and individual nurse care managers.

    • Main Results:

    • Significant decreases in mortality and hospitalization rates reported by management organizations.
    • Improvements in patient satisfaction and quality of life observed.
    • Evidence suggests disease management is realizing its promise of improved care at reduced cost in ESRD.

    Conclusions:

    • Disease management programs are effective in improving care and reducing costs for patients with end-stage renal disease (ESRD).
    • The comprehensive measurement of clinical outcomes and total healthcare costs is essential for fully defining the impact of these programs.
    • Findings have significant implications for shaping future United States healthcare policy for ESRD.